moexipril hydrochloride

Generic: moexipril hydrochloride

Labeler: glenmark pharmaceuticals inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name moexipril hydrochloride
Generic Name moexipril hydrochloride
Labeler glenmark pharmaceuticals inc., usa
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

moexipril hydrochloride 15 mg/1

Manufacturer
Glenmark Pharmaceuticals Inc., USA

Identifiers & Regulatory

Product NDC 68462-208
Product ID 68462-208_66bb1c8f-1f66-4834-86a3-a387d076aa22
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090416
Listing Expiration 2027-12-31
Marketing Start 2010-12-31

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68462208
Hyphenated Format 68462-208

Supplemental Identifiers

RxCUI
1299896 1299897
UPC
0368462209011 0368462208014
UNII
Q1UMG3UH45

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name moexipril hydrochloride (source: ndc)
Generic Name moexipril hydrochloride (source: ndc)
Application Number ANDA090416 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01)
  • 1000 TABLET, FILM COATED in 1 BOTTLE (68462-208-10)
  • 90 TABLET, FILM COATED in 1 BOTTLE (68462-208-90)
source: ndc

Packages (3)

68462-208-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01) 68462-208-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-208-10) 68462-208-90 90 TABLET, FILM COATED in 1 BOTTLE (68462-208-90)

Ingredients (1)

moexipril hydrochloride (15 mg/1)

Linked Drug Pages (1)

Moexipril Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "66bb1c8f-1f66-4834-86a3-a387d076aa22", "openfda": {"upc": ["0368462209011", "0368462208014"], "unii": ["Q1UMG3UH45"], "rxcui": ["1299896", "1299897"], "spl_set_id": ["baac91ad-f8ee-4694-89f8-5c47a8eda39a"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01)", "package_ndc": "68462-208-01", "marketing_start_date": "20101231"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (68462-208-10)", "package_ndc": "68462-208-10", "marketing_start_date": "20101231"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (68462-208-90)", "package_ndc": "68462-208-90", "marketing_start_date": "20101231"}], "brand_name": "Moexipril Hydrochloride", "product_id": "68462-208_66bb1c8f-1f66-4834-86a3-a387d076aa22", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "68462-208", "generic_name": "Moexipril Hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Moexipril Hydrochloride", "active_ingredients": [{"name": "MOEXIPRIL HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA090416", "marketing_category": "ANDA", "marketing_start_date": "20101231", "listing_expiration_date": "20271231"}